阴阳离子表面活性剂混合体系对原油的乳化及增粘行为

利用阴阳离子表面活性剂复配技术,实现了高含水量原油体系的乳化及增粘. 通过调整表面活性剂分子结构,解决了阴阳离子表面活性剂复配体系在油田模拟水中的溶解度问题. 确定了相关体系高含水量油包水（W/O）乳状液的表面活性剂浓度,研究了可以产生高含水量油包水乳状液的油水混合体积比范围,并研究了温度、pH值、油水混合比例和离子强度对乳化及增粘作用的影响. 获得了一系列具有优良乳化效果和乳状液稳定性的体系,其中部分体系粘度可增大80倍. 这对于三次采油提高采收率有重要意义.     

阴阳离子表面活性剂混合体系对原油的乳化及增粘行为

利用阴阳离子表面活性剂复配技术,实现了高含水量原油体系的乳化及增粘.通过调整表面活性剂分子结构,解决了阴阳离子表面活性剂复配体系在油田模拟水中的溶解度问题.确定了相关体系高含水量油包水(W/O)乳状液的表面活性剂浓度,研究了可以产生高含水量油包水乳状液的油水混合体积比范围,并研究了温度、pH值、油水混合比例和离子强度对乳化及增粘作用的影响.获得了一系列具有优良乳化效果和乳状液稳定性的体系,其中部分体系粘度可增大80倍.这对于三次采油提高采收率有重要意义.     

利用手持技术探究不同洗涤剂乳化能力的强弱

影响洗涤剂去油污能力的关键因素是表面活性剂的乳化能力,为了探究不同洗涤剂乳化能力的强弱,先利用手持技术对常用表面活性剂十二烷基苯磺酸钠的水溶液进行了探究,结果发现乳化能力的强弱可以通过乳状液的电导率下降比率来反映。因此利用手持技术,通过电导率传感器采集不同洗涤剂与植物油混合搅拌时乳状液的电导率下降比率,来判断其去油污能力的强弱。     

疏水缔合共聚物与表面活性剂的界面相互作用

采用界面张力弛豫法研究了疏水缔合聚合物聚丙烯酰胺/2-乙基己基丙烯酸酯[P(AM/2-EHA)]在正辛烷-水界面上的扩张粘弹性质, 考察了不同类型表面活性剂十二烷基硫酸钠(SDS)、聚环氧乙烯醚(Tx-100)和十六烷基三甲基溴化铵(CTAB)对其界面扩张性质的影响. 研究发现, 界面上的表面活性剂分子可以与聚合物的疏水嵌段形成类似混合胶束的聚集体, 表面活性剂分子与聚集体之间存在快速交换. 这种弛豫过程的特征时间远比分子在体相与界面间的扩散交换时短. 当界面面积增大时, 上述混合胶束中的表面活性剂分子能快速释放, 在界面层内原位快速消除界面张力梯度, 从而大大降低界面扩张弹性. 界面上的CTAB分子与聚合物链节上的负电中心通过较强的电荷吸引作用形成复合物. 当界面面积增大时, 上述混合胶束中的CTAB分子释放较慢, 界面张力梯度较大. 非离子表面活性剂Tx-100分子量较大, 扩散速率较慢, 它在界面上与聚集体间的交换比阴离子表面活性剂SDS慢, 其特征时间约为0.9 s.     

共溶剂性质对双亲性无规共聚物P(St-co-DM)胶束化行为及其性能的影响

以苯乙烯(St)和甲基丙烯酸二甲氨乙酯(DMAEMA)为共聚单体, 通过普通自由基溶液聚合合成了双亲性无规共聚物P(St-co-DM). 用傅里叶变换红外(FTIR)光谱、核磁共振氢谱(¹H NMR)、凝胶渗透色谱(GPC)和差示扫描量热(DSC)仪对聚合物结构进行表征. 研究了共溶剂的性质对P(St-co-DM)自组装胶束结构及其乳化性能的影响. 用透射电镜(TEM)和动态激光光散射(DLS)表征了自组装胶体粒子的形态、粒径大小及其分布. 通过测量胶束在甲苯/水界面的接触角表征胶束表面性能. 结果表明: P(St-co-DM)以四氢呋喃(THF)为共溶剂自组装时, 胶束的临界聚集水含量较大, 胶束表面亲水性较强, 流体力学半径较大; 用二氧六环或THF为共溶剂, 水为选择性溶剂, P(St-co-DM)自组装可以得到外层松散、内层比较密实的球状胶束, 用N,N-二甲基甲酰胺(DMF)为共溶剂时, 胶束整体呈现比较密实的球状胶束; 分别用DMF、二氧六环和THF为共溶剂制备的胶束, 其接触角均值都小于90°, 可形成O/W型(水包油型)乳液. 乳化实验结果表明, 以二氧六环和THF为共溶剂制备的胶束作为颗粒乳化剂制备的乳液性能较好.     

离子型表面活性剂自组装体系在化学中的应用

本文介绍了离子型表面活性剂在氧化物表面自组装体系的原理及特点,离子型表面活性剂分子从溶液中自发地吸附到氧化物表面形成单分子胶束、双分子胶束和混合胶束,该体系对许多疏水性有机化合物以及经螯合有机基团的金属离子具有很强的吸附富集作用,本文根据不同自组装体系的结构分类详述了它们在分析化学和环境化学中应用研究,并且展望了该技术的应用前景。     

超分子模板法合成层状中孔结构氧化铝

利用烷基硫酸钠作为模板剂在室温下合成了层状中孔结构氧化铝,考察了表面活性剂碳链长度和表面活性剂混合比例对层状氧化铝中孔相结构参数的影响.当使用单一表面活性剂作为模板剂时,层状中孔结构氧化铝的层间距d及其层状结构的长程有序度随着表面活性剂碳链长度的增加而增加;若使用C₈H₁₇SO₄Na与C₁₄H₂₉SO₄Na混合表面活性剂作为混合模板剂,当C₁₄H₂₉SO₄Na摩尔分数x处在0～0.5时,层间距基本恒定,接近于具有二者平均碳链长度(n=11)的单一表面活性剂作为模板剂时的情形;当x>0.5时,层间距随x的增大而逐渐增大.通过提出的混合表面活性剂在无机层中的分子排列结构模型对该结果做了解释.     

正负离子和表面活性剂对水解聚丙烯酰胺分子线团尺寸的影响及其作用机理

采用动态光散射(DLS)方法,研究了无机电解质正离子与负离子对部分水解聚丙烯酰胺(HPAM)分子线团尺寸的影响,也研究了阴离子型表面活性剂与非离子型表面活性剂对HPAM分子线团尺寸的影响.结果表明,无机电解质负离子对HPAM分子尺寸(分子流体力学直径(Dh))影响较小,而无机电解质正离子对Dh的影响较大,且影响程度随正离子浓度增大而减小.Ca2+、Mg2+、K+和Na+对Dh的作用强弱顺序为Mg2+>Ca2+>Na+>K+.当向聚合物溶液中加入阴离子型表面活性剂时,随表面活性剂浓度增大,Dh先减小,后增大,再减小.此外,由于强烈的静电斥力作用,阴离子型表面活性剂分子在聚合物分子表面吸附较弱,难形成"表面活性剂-聚合物"络合物,而非离子型表面活性剂会以类似于胶束聚集体的形式吸附在聚合物分子链上,形成"表面活性剂-聚合物"络合物,结果造成Dh随表面活性剂浓度增加而逐渐增大.     

琥珀酸酯磺酸盐Gemini表面活性剂的合成及表面活性

以1-十二醇、1-十四醇、1-十六醇、1-十八醇、马来酸酐和乙二醇为主要原料,合成4种琥珀酸酯磺酸盐Gemini表面活性剂;借助红外光谱和核磁共振氢谱对所合成的化合物结构进行了表征。 4种表面活性剂均具有较低的临界胶束浓度,较强的乳化性能以及较好的泡沫性能。 进一步讨论了4种表面活性剂结构与性能的关系。     

疏水缔合聚丙烯酰胺与双子表面活性剂的相互作用

制备了一种脂肪酸酯双磺酸盐型双子表面活性剂, 利用粘度法、界面张力法和原子力显微镜研究了疏水缔合聚丙烯酰胺与双子表面活性剂在溶液中的相互作用. 实验结果表明: 疏水缔合聚丙烯酰胺在溶液中能够通过自组装形成疏水微区并发展成网络结构, 疏水微区与表面活性剂在溶液中能形成混合胶束; 当一定量的表面活性剂加入时, 对疏水缔合聚丙烯酰胺的自组装起促进作用, 而过多双子表面活性剂的加入又会对聚合物分子的自组装起抑制作用, 从而显著影响疏水缔合聚丙烯酰胺的溶液性质, 随着表面活性剂浓度的增加, 聚合物溶液粘度先增加、再降低; 同时, 疏水缔合聚丙烯酰胺对双子表面活性剂的界面性能也有较大影响, 聚合物的加入使双子表面活性剂降低油/水界面张力的能力下降, 油/水界面张力达到平衡所需时间延长.     

Paliperidone-Loaded Self-Emulsifying Drug Delivery Systems (SEDDS) for Improved Oral Delivery

The present research is aimed to improve the oral delivery of paliperidone by loading into self-emulsifying drug delivery systems (SEDDS). Oleic acid, Tween 80, and capmul MCM L8 were selected as oil, surfactant, and co-surfactant, respectively and phase diagram was constructed and the region was identified for the formation of SEDDS. The stable formulations were analyzed for globule size, robustness to dilution and in vitro drug release. The globule size of all the formulations was found to be in the range of 205 to 310 nm with good size uniformity and seems to be dependent on the proportion of oil in SEEDS formulation. The optimized formulation (F3) has been adsorbed onto neusilin and characterized. The DSC and XRD spectra unravel the presence of molecular state of paliperidone in solid SEDDS. The in vitro dissolution study indicates improved dissolution characteristics with higher dissolution efficiency for solid SEDDS (SEDDS-N) compared to pure drug. Further ex vivo permeation studies carried out using rat intestine suggest a 2- to 3-fold improvement in permeation for SEDDS compared to pure drug. In conclusion, SEDDS prove to be potential carriers for improved oral delivery of paliperidone.     

Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles

Lipid-polymer hybrid nanoparticles are polymeric nanoparticles enveloped by lipid layers that combine the highly biocompatible nature of lipids with the structural integrity afforded by polymeric nanoparticles. Recognizing them as attractive drug delivery vehicles, antibiotics are encapsulated in the present work into hybrid nanoparticles intended for lung biofilm infection therapy. Modified emulsification-solvent-evaporation methods using lipid as surfactant are employed to prepare the hybrid nanoparticles. Biodegradable poly (lactic-co-glycolic acid) and phosphatidylcholine are used as the polymer and lipid models, respectively. Three fluoroquinolone antibiotics (i.e. levofloxacin, ciprofloxacin, and ofloxacin), which vary in their ionicity, lipophilicity, and aqueous solubility, are used. The hybrid nanoparticles are examined in terms of their drug encapsulation efficiency, drug loading, stability, and in vitro drug release profile. Compared to polymeric nanoparticles prepared using non-lipid surfactants, hybrid nanoparticles in general are larger and exhibit higher drug loading, except for the ciprofloxacin-encapsulated nanoparticles. Hybrid nanoparticles, however, are unstable in salt solutions, but the stability can be conferred by adding TPGS into the formulation. Drug-lipid ionic interactions and drug lipophilicity play important roles in the hybrid nanoparticle preparation. First, interactions between oppositely charged lipid and antibiotic (i.e. ciprofloxacin) during preparation cause failed nanoparticle formation. Charge reversal of the lipid facilitated by adding counterionic surfactants (e.g. stearylamine) must be performed before drug encapsulation can take place. Second, drug loading and the release profile are strongly influenced by drug lipophilicity, where more lipophilic drug (i.e. levofloxacin) exhibit a higher drug loading and a sustained release profile attributed to the interaction with the lipid coat.     

Formulation,Characterization and Permeability Studies of Fenugreek (Trigonella foenum-graecum) Containing Self-Emulsifying Drug Delivery System (SEDDS)

Fenugreek is used as a spice and a traditional herbal medicine for a variety of purposes, given its antidiabetic and antioxidant effects. Self-emulsifying drug delivery systems (SEDDS) of herbal drugs are targets of extensive research aiming to increase bioavailability and stability. The study’s objective was to formulate SEDDS containing Trigonella foenum-graecum extract to improve the stability of herbal extract and to increase their permeability through a Caco-2 monolayer. A characterized fenugreek dry extract was used for the formulations, while the SEDDS properties were examined by particle size analysis and zeta potential measurements. Permeability assays were carried out on Caco-2 cell monolayers, the integrity of which was monitored by follow-up trans-epithelial electric resistance measurements (TEER). Cytocompatibility was tested by the MTT method, and an indirect dissolution test was performed, using DPPH antioxidant reagent. Two different SEDDS compositions were formulated from a standardized fenugreek dry extract at either the micro- or the nanoemulsion scale with sufficient stability, enhanced bioavailability of the compounds, and sustained release from HPMC capsules. Based on our results, a modern, non-toxic, cytocompatible fenugreek SEDDS formulation with high antioxidant capacity was developed in order to improve the permeability and bioavailability of all components.     

Self-emulsification in chemical and pharmaceutical technologies

The interest in the low energy self-emulsification techniques has exploded in the recent years, driven by three main trends: by the transition to “greener” technologies in both its aspects—less energy consumption and replacement of the petrochemicals by natural ingredients; by the costly and maintenance demanding equipment for nanoemulsification; and by the quest for efficient and robust self-emulsifying formulations for oral drug delivery. Here, we first present a brief overview of the main known low-energy methods for nanoemulsion formation, focusing on their mechanistic understanding and discussing some recent advances in their development and applications. Next, we review three conceptually new approaches for self-emulsification in chemical technologies, discovered in the last several years. The colloidal features and the specific requirements of the self-emulsifying drug-delivery systems (SEDDS) are also discussed briefly. Finally, we summarize the current trends and the main challenges in this vivid research area.     

Improving the high variable bioavailability of griseofulvin by SEDDS

To enhance the dissolution and oral absorption of poorly water-soluble griseofulvin (GF), self-emulsifying drug delivery system (SEDDS) composed of oil, surfactant and cosurfactant for oral administration of griseofulvin was formulated, and its physicochemical properties and pharmacokinetic parameters were evaluated. The solubility of griseofulvin was further improved by the addition of hydrochloric acid. Droplet size of griseofulvin emulsion was kept constant both in simulated gastric fluid without pepsin and simulated intestinal fluid throughout 12 weeks incubation period. Griseofulvin in the SEDDS rapidly dissolved in different dissolution media. This was not the case for the commercial GRIS-PEG tablets. In different fed diet groups, AUC 0-->24 h, Cp max, and T max of griseofulvin after oral administration of SEDDS in rats were comparable to those after oral dose of GRIS-PEG tablet. Although, in fed lipidic diet group, the mean AUC and Cp max after oral administration of GRIS-PEG in rats were 1.28 and 1.15 fold higher, respectively, compared with those of SEDDS, these have not shown to be significantly different. These results demonstrate that the SEDDS of griseofulvin composed of Capmul GMO-50, Poloxamer and Myvacet 9-45 greatly enhanced the dissolution of griseofulvin (without ultramicronisation). However, food intake effect on the bioavailability of griseofulvin has remained. Thus, this system may provide a useful dosage form for oral water-insoluble drugs which have problems in their dissolution.     

正负离子表面活性剂与两性表面活性剂的相互作用

本文研究正负离子表面活性剂与两性表面活性剂混合水溶液的表面性质, 以及两性表面活性剂对正负离子裘面活性剂溶解度的影响。结果表明: (1) 两性表面活性剂的加溶作用,有助于正负离子表面活性剂的溶解; (2) 加入两性表面活性剂的量适当, 混合溶液基本保持原正负离子表面活性剂的表面活性; (3) 正负离子表面活性剂与两性表面活性剂在表面层和胶团中分子间的相互作用比正负离子表面活性剂与非离子表面活性剂分子间的相互作用稍强HC-FC正负; 离子表面活性剂与两性表面活性剂混合体系在表面层中有可能形成双分子或多分子层结构。     

The hydrophobic effect

This review is a brief discussion on the development of the understanding of hydrophobicity, or the hydrophobic effect. The hydrophobic effect is primarily discussed in terms of partitioning of hydrocarbons between a hydrophobic environment and water as well as solubility of hydrocarbons in water. Micellization of surfactants is only briefly reviewed.It is emphasized that (i) the cause of the hydrophobic effect, e.g. the low solubility of a hydrocarbon in water, is to be found in the high internal energy of water resulting in a high energy to create a cavity in order to accommodate the hydrophobe, (ii) the “structuring” of water molecules around a hydrophobic compound increases the solubility of the hydrophobe. The “structuring” of water molecules around hydrophobic compounds is discussed in terms of recent spectroscopic findings. It is also emphasized that (iii) the lowering of entropy due to a structuring process must be accompanied by an enthalpy that is of the same order of magnitude as the TΔS for the process. Hence, there is an entropy–enthalpy compensation leading to a low free energy change for the structuring process. The assumption of a rapid decay of the entropy with temperature provides an explanation of the enthalpy–entropy compensation so often found in aqueous systems. It is also emphasized (iv) that the free energy obtained from partitioning, or solubility limits, needs to be corrected for molecular size differences between the solute and the solvent. The Flory–Huggins expression is a good first approximation for obtaining this correction. If the effect of different molecular sizes is not corrected for, this leads to erroneous conclusions regarding the thermodynamics of the hydrophobic effect. Finally, (v) micellization and adsorption of surfactants, as well as protein unfolding, are briefly discussed in terms of the hydrophobic effect.     

Syntheses of complex mesoporous silicas using mixtures of nonionic block copolymer surfactants: understanding formation of different structures using solubility parameters

The use of block copolymer (BCP) nonionic surfactant mixtures (including Pluronic, Brij and Tetronic types) as templates for synthesizing porous silica materials of mixed pore sizes is explored here. These systems have important applications because combinations of pore sizes can allow rapid access of reactants (via large pores) whilst providing the very high surface area of small pores for higher reaction rates or size selectivity. Examples of the materials prepared here include pore size bimodal hexagonal p6mm channel structures and cubic Im3m cage structures. It is shown here that the chemical similarity, as indicated by the solubility parameter, of the surfactants is an important factor in determining the pore structure and size distribution (PSD) of the pores. Monomodal pore structures are usually obtained when the solubility parameters of the surfactants are similar and bimodal pore structures when the solubility parameters are reasonably different. When the interaction parameter is very high disordered porous systems are formed. Ternary co-surfactant systems, e.g. P123-25R4-P65, can also yield highly ordered bimodal mesoporous silica with a hexagonal structure.